Skip to main content
. 2019 Oct 1;8(10):1566. doi: 10.3390/jcm8101566

Figure 6.

Figure 6

Kaplan–Meier curve for RECIST-PFS (A) and OS (B) based on the expression of B7-H4 defined as ≥1% vs. <1% in the Nivolumab Cohort. The expression of B7-H4 was significantly associated with shorter PFS and non-significantly associated with shorter OS, although the difference was close to significance (p-value = 0.064).